Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 05 - 24 tags : Positive save search
Aptorum Group Announces Positive Interim Phase I Clinical Trial Progress for ALS-4 Targeting Staphylococcus aureus and Positive Pre-IND Progress for SACT-1 Targeting Neuroblastoma
Published: 2021-05-24 (Crawled : 13:00) - biospace.com/
APM | $5.59 -22.9% -29.93% 120K
|
Health Technology
|
| O: 9.75%
H: 35.53%
C: 7.2%
positive trial als staphylococcus aureus
BrainsWay Announces First of its Kind Positive Coverage Policy by Centene for the Treatment of OCD Utilizing Deep TMS™
Published: 2021-05-24 (Crawled : 12:15) - globenewswire.com
CNC | $73.75 2.43% 0.0% 5.1M
|
Health Services
|
| O: 0.31%
H: 0.58%
C: -0.05%
BWAY | $4.8 -4.95% -5.21% 80K
|
Health Technology
|
| O: 12.93%
H: 2.5%
C: -2.11%
treatment positive
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) in Combination With Chemotherapy as First-Line Treatment for Certain Patients With Esophageal Cancer or HER2-Negative Gastroesophageal Junction (GEJ) Adenocarcinoma
Published: 2021-05-24 (Crawled : 12:00) - biospace.com/
MRK | $125.23 -0.11% 0.0% 6M
|
Health Technology
|
| O: 0.44%
H: 0.15%
C: -0.63%
treatment positive therapy cancer chmp her2+ keytruda her2- her2
Iridium Makes Strategic Investment in DDK Positioning, Provider of Enhanced GNSS Accuracy Solutions
Published: 2021-05-24 (Crawled : 12:00) - prnewswire.com
IRDM | News | $26.06 5.46% 5.18% 2.1M
|
Communications
|
| O: 0.87%
H: 0.91%
C: 0.08%
positive
Positive Clinical Data About Axcella’s AXA1665 Candidate for Overt Hepatic Encephalopathy Highlighted in Oral Presentation at DDW 2021
Published: 2021-05-24 (Crawled : 12:00) - biospace.com/
AXLA | $4.58 -56.33% 42K
|
Health Technology
|
| O: 7.19%
H: 3.88%
C: -12.01%
presentation positive hepatitis
4D pharma Presents Additional Positive Results of Phase II Study of Blautix® for the Treatment of Irritable Bowel Syndrome
Published: 2021-05-24 (Crawled : 06:00) - 4dpharmaplc.com
LBPS | $1.65 -0.61%
|
Manufacturing
| Email alert
Add to watchlist
positive treatment positive results results syndros
Libtayo® (cemiplimab) Receives Positive CHMP Opinion for the Treatment in Europe of Two Advanced Cancers
Published: 2021-05-24 (Crawled : 06:00) - prnewswire.com
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.02%
H: 0.3%
C: -0.3%
REGN | $893.66 -0.84% -0.84% 450K
|
Health Technology
|
| O: 0.6%
H: 0.0%
C: -1.82%
treatment europe positive cancer chmp
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.